Therapeutic innovations: targeting ROS production in AML with natural and synthetic compounds.

Naunyn-Schmiedeberg's Archives of Pharmacology | 2025

DOI: https://doi.org/10.1007/s00210-025-04054-6

The pathological role of C-X-C chemokine receptor type 4 (CXCR4) in colorectal cancer (CRC) progression; special focus on molecular mechanisms and possible therapeutics

Pathology Research and Practice | 2023

DOI: https://doi.org/10.1016/j.prp.2023.154616

Targeting Adenosine Receptors in Neurological Diseases

Cellular reprogramming | 2021

DOI: https://doi.org/10.1089/cell.2020.0087

Tyrosinase (TYR) gene sequencing and literature review reveals recurrent mutations and multiple population founder gene mutations as causative of oculocutaneous albinism (OCA) in Pakistani families

Eye | 2019

DOI: https://doi.org/10.1038/s41433-019-0436-9